Literature DB >> 12296379

The distribution of cofilin and DNase I in vivo.

Deepak Chhabra1, Shisan Bao, Cristobal G dos Remedios.   

Abstract

Actin is the principal component of the cytoskeleton, a structure that can be disassembled and reassembled in a matter of seconds in vivo. The state of assembly of actin in vivo is primarily regulated by one or more actin binding proteins (ABPs). Typically, the actions of ABPs have been studied one by one, however, we propose that multiple ABPs, acting cooperatively, may be involved in the control of actin filament length. Cofilin and DNase I are two ABPs that have previously been demonstrated to form a ternary complex with actin in vitro. This is the first report to demonstrate their co-localisation in vivo, and differences in their distributions. Our observations strongly suggest a physiological role for higher order complexes of actin in regulation of cytoskeletal assembly during processes such as cell division.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296379     DOI: 10.1038/sj.cr.7290126

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  4 in total

1.  Professor Cristobal G dos Remedios mentorship.

Authors:  Shisan Bob Bao
Journal:  Biophys Rev       Date:  2020-07-13

2.  Cofilin, actin and their complex observed in vivo using fluorescence resonance energy transfer.

Authors:  D Chhabra; C G dos Remedios
Journal:  Biophys J       Date:  2005-07-01       Impact factor: 4.033

Review 3.  A review of actin binding proteins: new perspectives.

Authors:  Ricardo Uribe; David Jay
Journal:  Mol Biol Rep       Date:  2007-10-16       Impact factor: 2.316

4.  Human Recombinant DNase I (Pulmozyme®) Inhibits Lung Metastases in Murine Metastatic B16 Melanoma Model That Correlates with Restoration of the DNase Activity and the Decrease SINE/LINE and c-Myc Fragments in Blood Cell-Free DNA.

Authors:  Ludmila Alekseeva; Aleksandra Sen'kova; Innokenty Savin; Marina Zenkova; Nadezhda Mironova
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.